![Micro-cap Pavmed takes on Medtronic, Exact with first DNA-based Barrett's esophagus test | 2019-12-27 | BioWorld Micro-cap Pavmed takes on Medtronic, Exact with first DNA-based Barrett's esophagus test | 2019-12-27 | BioWorld](https://www.bioworld.com/ext/resources/BMT-source/2019/Pavmed-luciddx-EsoCheck-procedure-12-27.png)
Micro-cap Pavmed takes on Medtronic, Exact with first DNA-based Barrett's esophagus test | 2019-12-27 | BioWorld
![Micro-cap Pavmed takes on Medtronic, Exact with first DNA-based Barrett's esophagus test | 2019-12-27 | BioWorld Micro-cap Pavmed takes on Medtronic, Exact with first DNA-based Barrett's esophagus test | 2019-12-27 | BioWorld](https://www.bioworld.com/ext/resources/BMT-source/2019/Pavmed-luciddx-EsoCheck-12-27.png?1577469753)
Micro-cap Pavmed takes on Medtronic, Exact with first DNA-based Barrett's esophagus test | 2019-12-27 | BioWorld
![PAVmed (PAVM) on Twitter: "A minimally invasive procedure with the therapeutic results of open surgery. CarpX is designed to closely mimic the anatomic results of invasive carpal tunnel surgery, but much less PAVmed (PAVM) on Twitter: "A minimally invasive procedure with the therapeutic results of open surgery. CarpX is designed to closely mimic the anatomic results of invasive carpal tunnel surgery, but much less](https://pbs.twimg.com/ext_tw_video_thumb/1291047728890277888/pu/img/rl6LwJDmKuSn39bF.jpg:large)
PAVmed (PAVM) on Twitter: "A minimally invasive procedure with the therapeutic results of open surgery. CarpX is designed to closely mimic the anatomic results of invasive carpal tunnel surgery, but much less
![PAVmed's Esophageal Diagnostic Tools Should Create Strong Shareholder Value (NASDAQ:PAVM) | Seeking Alpha PAVmed's Esophageal Diagnostic Tools Should Create Strong Shareholder Value (NASDAQ:PAVM) | Seeking Alpha](https://static.seekingalpha.com/uploads/2020/12/29/4562691-16092847084865537_origin.png)
PAVmed's Esophageal Diagnostic Tools Should Create Strong Shareholder Value (NASDAQ:PAVM) | Seeking Alpha
![PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results | Business Wire PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results | Business Wire](https://mms.businesswire.com/media/20211116006357/en/927959/23/PAVMED_LOGO.jpg)
PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results | Business Wire
![Episode 19: Dr. Lishan Aklog, Chairman and CEO at PAVmed Inc. — bioaccess.™: CRO. REGULATORY. COMMERCIALIZATION Episode 19: Dr. Lishan Aklog, Chairman and CEO at PAVmed Inc. — bioaccess.™: CRO. REGULATORY. COMMERCIALIZATION](https://images.squarespace-cdn.com/content/v1/5204349be4b0255b5ad580aa/1572715818067-RE3YL0SN57OHL0U7MQ4S/numeros_bioaccess-13.png?format=750w)